Follow the 올리패스 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 올리패스 has published 97 public disclosures. The latest transaction was filed on 15 December 2025 (Purchase). Among the most active insiders: 제노큐어. The full history is free.
97
Insider Decl.
n/a
Thresholds
n/a
83 ops.
Buy Volume
n/a
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
OliPass is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative treatments and therapeutic solutions.